DROSPIRENON/ETHINYLESTRADIOL WH-PHARMA

3MG/0,02MG TBL FLM 13X28(21+7)

SÚKL code 0220763
Name of the product DROSPIRENON/ETHINYLESTRADIOL WH-PHARMA
_MA_MEDICATION_DETAIL_INFO_MED_NAME i DROSPIRENON/ETHINYLESTRADIOL WH-PHARMA
Supplement 3MG/0,02MG TBL FLM 13X28(21+7)
Strenght 3MG/0,02MG
Pharmaceutical form Film-coated tablet
Package 13X28(21+7)
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance ETHINYLESTRADIOL (ETHINYLESTRADIOLUM)
DROSPIRENONE (DROSPIRENONUM)
ATC group G03AA12
ATC group name DROSPIRENON A ETHINYLESTRADIOL

Marketing authorisation information

Registration Number 17/1046/16-C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 01. 2020
MA Holder WH-Pharma s.r.o., Kutná Hora
MA Holder country ČESKÁ REPUBLIKA
Actual MA holder Aristo Pharma GmbH, Berlin
Actual MA holder country NĚMECKO

Back to list